SG Americas Securities

SG Americas Securities’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

SG Americas Securities’s Portfolio GEVA Stock Details GEVA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell
2015 Q1	$114K	Sell
2014 Q4	$547K	Buy
2014 Q3	$181K	Buy
2014 Q2	–	Sell
2014 Q1	$802K	Buy
2013 Q4	–	Sell
2013 Q3	$192K	Buy